These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art]. Kordon A; Zurowski B; Wahl K; Hohagen F Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636 [TBL] [Abstract][Full Text] [Related]
48. Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder. Marazziti D; Pallanti S Am J Psychiatry; 1999 Nov; 156(11):1834-5. PubMed ID: 10553756 [No Abstract] [Full Text] [Related]
49. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series. Weiss EL; Potenza MN; McDougle CJ; Epperson CN J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634 [TBL] [Abstract][Full Text] [Related]
50. Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features. Strous RD; Patel JK; Zimmet S; Green AI Am J Psychiatry; 1999 Jun; 156(6):973-4. PubMed ID: 10360153 [No Abstract] [Full Text] [Related]
51. When Improving Symptoms Is Not Enough-Is It Time for Next-Generation Interventions for Obsessive-Compulsive Disorder? Mataix-Cols D; Fernández de la Cruz L; Rück C JAMA Psychiatry; 2020 Jan; 77(1):9-10. PubMed ID: 31509171 [No Abstract] [Full Text] [Related]
52. Combined pharmacotherapy for TS and OCD. Hawkridge S; Stein DJ; Bouwer C J Am Acad Child Adolesc Psychiatry; 1996 Jun; 35(6):703-4. PubMed ID: 8682749 [No Abstract] [Full Text] [Related]